PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23462987-4	2013	nAbs-Abeta were able to reduce toxic oligomer concentration with an increase in Abeta-monomers.	nabs	0-4	amyloid beta (A4) precursor protein	Mus musculus	5-10	
26907803-4	2016	In this study, we identified naturally occurring autoantibodies against Abeta oligomers (NAbs-Abetao), which were purified by Abeta42 oligomer or Cibacron Blue affinity chromatography from IVIG and termed as Oli-NAbs and Blue-NAbs, respectively.	nabs	89-93	amyloid beta (A4) precursor protein	Mus musculus	72-77	
23462987-4	2013	nAbs-Abeta were able to reduce toxic oligomer concentration with an increase in Abeta-monomers.	nabs	0-4	amyloid beta (A4) precursor protein	Mus musculus	80-85	
21490226-4	2011	Here, we further investigated their physiological role: in epitope mapping studies, NAbs-Abeta recognized the mid-/C-terminal end of Abeta and preferentially bound to oligomers but failed to bind to monomers/fibrils.	nabs	84-88	amyloid beta (A4) precursor protein	Mus musculus	133-138	
21490226-4	2011	Here, we further investigated their physiological role: in epitope mapping studies, NAbs-Abeta recognized the mid-/C-terminal end of Abeta and preferentially bound to oligomers but failed to bind to monomers/fibrils.	nabs	84-88	amyloid beta (A4) precursor protein	Mus musculus	89-94	
21490226-5	2011	NAbs-Abeta were able to interfere with Abeta peptide toxicity, but NAbs-Abeta did not readily clear senile plaques although early fleecy-like plaques were reduced.	nabs	0-4	amyloid beta (A4) precursor protein	Mus musculus	5-10	
21490226-5	2011	NAbs-Abeta were able to interfere with Abeta peptide toxicity, but NAbs-Abeta did not readily clear senile plaques although early fleecy-like plaques were reduced.	nabs	0-4	amyloid beta (A4) precursor protein	Mus musculus	39-44	
21490226-5	2011	NAbs-Abeta were able to interfere with Abeta peptide toxicity, but NAbs-Abeta did not readily clear senile plaques although early fleecy-like plaques were reduced.	nabs	0-4	amyloid beta (A4) precursor protein	Mus musculus	39-44	
35570231-6	2022	Furthermore, NAbs-Bim purified from intravenous immunoglobulin rescued the behavioral deficits and ameliorated Abeta deposition, tau hyperphosphorylation, microgliosis, and neuronal apoptosis in APP/PS1 mice.	nabs	13-17	amyloid beta (A4) precursor protein	Mus musculus	111-116	
35570231-7	2022	In vitro investigations demonstrated that NAbs-Bim were neuroprotective against AD through neutralizing Bim-directed neuronal apoptosis and the amyloidogenic processing of amyloid precursor protein.	nabs	42-46	amyloid beta (A4) precursor protein	Mus musculus	172-197